Logo
Apparel & Fashion

Loading subcategories...

View More

Description

Goserelin Acetate Injection represents a sophisticated synthetic analogue of gonadotropin-releasing hormone (GnRH) developed for advanced hormone therapy applications. This pharmaceutical innovation mimics natural GnRH activity while providing controlled suppression of sex hormone production through regular administration. Available in both 4-week (3.6 mg) and 3-month implant formulations, it offers healthcare professionals flexible treatment options for various hormone-dependent medical conditions. The injection delivers consistent and predictable hormone suppression, establishing itself as a reliable choice for long-term therapy management. Its unique mechanism involves initial stimulation followed by sustained suppression of pituitary gonadotropins, resulting in significantly reduced testosterone production in men and estrogen levels in women. This sophisticated action makes it particularly valuable for treating conditions that respond effectively to hormonal manipulation.

This med...
Goserelin Acetate Injection represents a sophisticated synthetic analogue of gonadotropin-releasing hormone (GnRH) developed for advanced hormone therapy applications. This pharmaceutical innovation mimics natural GnRH activity while providing controlled suppression of sex hormone production through regular administration. Available in both 4-week (3.6 mg) and 3-month implant formulations, it offers healthcare professionals flexible treatment options for various hormone-dependent medical conditions. The injection delivers consistent and predictable hormone suppression, establishing itself as a reliable choice for long-term therapy management. Its unique mechanism involves initial stimulation followed by sustained suppression of pituitary gonadotropins, resulting in significantly reduced testosterone production in men and estrogen levels in women. This sophisticated action makes it particularly valuable for treating conditions that respond effectively to hormonal manipulation.

This medication finds extensive application in oncology departments for treating advanced prostate cancer in male patients and specific types of breast cancer in female patients. Within gynecology practice, it provides effective management of endometriosis by creating a temporary menopausal state that alleviates symptoms and prevents disease progression. Hospitals, comprehensive cancer treatment centers, and specialized clinics incorporate Goserelin Acetate into their standard treatment protocols worldwide. The product serves medical professionals who require dependable hormone suppression therapy for their patients, particularly those needing long-term management of hormone-responsive conditions. Its clinical applications extend across both curative and palliative care settings, demonstrating versatility throughout different treatment stages and patient needs.

The business value of Goserelin Acetate Injection lies in its proven reliability and consistent performance across diverse clinical environments. Medical distributors and pharmaceutical wholesalers can confidently supply this product to healthcare providers, assured that it meets stringent quality standards and delivers predictable therapeutic outcomes. The availability of both 4-week and 3-month formulations provides essential treatment flexibility, allowing healthcare facilities to select the option that best aligns with their patient care protocols and administration schedules. This product represents a trusted solution for hormone therapy requirements, supported by established clinical evidence and manufacturing excellence. Its reliability and proven track record make it a valuable addition to any pharmaceutical portfolio serving oncology and gynecology specialists worldwide.

Key Features:
- Synthetic GnRH analogue providing precise hormone suppression
- Available in 3.6 mg 4-week and 3-month implant formulations
- Consistent quality manufacturing meeting pharmaceutical standards
- Flexible dosing options accommodating different treatment protocols
- Controlled release mechanism ensuring sustained therapeutic effect

Benefits:
- Effective hormone level reduction for cancer therapy
- Reliable treatment outcomes with predictable results
- Flexible administration options for varied clinical needs
- Trusted quality meeting international standards
- Sustained therapeutic effect reducing administration frequency

Specifications

Additional Information
Country of OriginIndia
CustomisableNo

Application

Goserelin Acetate Injection serves as a critical therapeutic agent in oncology and gynecology for hormone-dependent conditions. It provides effective treatment for prostate cancer in men and breast cancer in women through targeted hormone suppression. The medication also offers significant relief for endometriosis symptoms by controlling estrogen production. Available in both 4-week and 3-month formulations, it accommodates various treatment protocols and patient requirements across different healthcare settings. This pharmaceutical product is essential for hospitals, cancer treatment centers, and specialty clinics managing hormone-related disorders. Medical distributors and wholesalers can rely on its consistent quality for supplying healthcare providers requiring dependable hormone therapy solutions. The injection format ensures precise dosing and controlled release, making it suitable for clinical administration and long-term patient care programs. Its reliability makes it a preferred choice for medical professionals treating complex hormonal conditions. - Prostate cancer hormone therapy for male patients in clinical settings - Breast cancer management through estrogen suppression in women - Endometriosis treatment for symptom relief and hormonal control - Hospital oncology department protocols for advanced cancer care - Specialty clinic programs for hormone-related disorder management

Trade Details

Available StockIn Stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Custom Terms (manual entry)

Company Profile

Biogenix Pharma UK Limited, Maharashtra
TruBasic
IndiaMaharashtra, India
Manufacturer
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

Pharmaceutical Goserelin Acetate Injection For Cancer Hormone Therapy

Goserelin Acetate Injection is a synthetic GnRH analogue for cancer hormone therapy, effectively reducing testosterone and estrogen levels with reliable 4-week or 3-month implant options for prostate cancer, breast cancer, and endometriosis treatment.

Min. Order Quantity: 1 unit

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

Biogenix Pharma UK Limited
Verified
IndiaMaharashtra, India
Manufacturer

More Products From Supplier